Erytech Pharma - ADR
ERYP
Get informed when a big investor buys or sells
+ FollowMarket Cap$47.38M
Close$
Share Statistics
| Market cap | $47.38 Million |
|---|---|
| Enterprise Value | $47.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 2.13 |
| Outstanding Shares | 31,016,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -16.95 |
| Enterprise Value to Net Income | 77 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Erytech Pharma
2,020 employees
CEO: Gil Beyen